Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Preliminary results with AG-7088 in humans presented at ICAAC

Oct. 1, 1999

Tamiflu, first oral influenza neuraminidase inhibitor, launched today in Switzerland

Oct. 1, 1999

Orally active antimalarial compound acts via a newly identified therapeutic target

Oct. 1, 1999

Corvas granted SBIR award for malaria research

Oct. 1, 1999

Detailed activity profile, predicted human pharmacokinetics of E-1010 presented at ICAAC

Sep. 30, 1999

News from ICAAC: characterization of water-soluble prodrug of the azole antifungal Sch-56592

Sep. 30, 1999

DHFR inhibitors designed by Roche for activity against resistant Gram-positive bacteria

Sep. 30, 1999

Novel class of quinoline-indoles: discovery, activity and pharmacokinetics discussed at ICAAC

Sep. 30, 1999

Immtech's treatment for parasitic infections to enter phase I clinical trials

Sep. 30, 1999

Identification of tetracycline resistance reverser reported at ICAAC by Pfizer

Sep. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...